Physician profile
Eric Chacko
NPI 1437654662
$1,594.00
in general payments reported to CMS, 2019-2025
18 companies · $920 in 2025
The $920 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.19 · 2023: $142 · 2024: $515 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,570 · Education: $7.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.80 |
| Education | $7.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $253.49 | 2023-2025 | Filspari |
| Novo Nordisk INC | $203.46 | 2023-2025 | Ozempic, Rybelsus |
| Amgen INC. | $153.10 | 2023-2025 | Tavneos, Parsabiv, Aranesp |
| Astrazeneca Pharmaceuticals Lp | $152.02 | 2023-2025 | Farxiga, Lokelma |
| Ardelyx, INC. | $142.66 | 2024-2025 | Ibsrela |
| Fresenius USA Marketing, INC. | $127.88 | 2022-2025 | Velphoro, Velphoro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.29 | 2025 | Jardiance |
| Calliditas Therapeutics US INC. | $95.32 | 2025 | Tarpeyo |
| Otsuka America Pharmaceutical, INC. | $80.24 | 2023-2025 | Jynarque |
| Akebia Therapeutics INC | $77.43 | 2024-2025 | Vafseo |
| Novartis Pharmaceuticals Corporation | $40.14 | 2025 | |
| Aurinia Pharma U.S., INC. | $27.46 | 2024 | Lupkynis |
| Baxter Healthcare | $26.46 | 2025 | Renal - Pd |
| Lilly USA, LLC | $22.37 | 2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $21.32 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cormedix INC. | $18.41 | 2024 | Defencath |
| Kyowa Kirin, INC. | $17.04 | 2024 | Crysvita |
| Mallinckrodt Hospital Products INC. | $16.91 | 2024 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Chacko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.